Innovent (688837.SH): Clinical trial application for XNW26018 tablets approved by the National Medical Products Administration

Zhitong Finance APP News, Sinovent (688837.SH) announced that the company received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration (NMPA). The company's independently developed XNW26018 tablets have obtained clinical trial approval from the National Medical Products Administration, and the company plans to conduct clinical trials for the treatment of infectious diseases such as community-acquired pneumonia caused by microorganisms sensitive to this product.